Share Your Expertise & Experience - Call for Speaker Proposals
Interested in being considered for presenting at one of ISPE's topic-focused conferences? Speaker proposals are currently being accepted for the following conferences: 2017 ISPE Pharmaceutical Serialization Workshops 8 – 9 May 2017 | Philadelphia, PA Submission Deadline: 28 February 2017, contact John Donaldson at jdonaldson@ispe.org2017 ISPE Process Validation Conference 12 – 14 September 2017 | Bethesda, MD Submission Deadline: 13 March 2017 2017 ISPE Process Validation Statistics Conference 13 – 15 September 2017 | Bethesda, MD Submission Deadline: 13 March 2017 2017 ISPE Biopharmaceutical Manufacturing Conference 4 – 7 December 2017 | San Francisco, CA Submission Deadline: 31 March 2017 2018 ISPE Aseptic Conference 6 – 7 March 2018 | Reston, VA Submission Deadline: 15 May 2017 2018 ISPE Quality Manufacturing Conference 4 – 6 June 2018 | Arlington, VA Submission Deadline: 15 July 2017
Digital Transformation (DT) is impacting every aspect of our personal and professional lives, so it was no surprise that nearly one-third of all presentation proposals for this year’s ISPE Annual Meeting involved DT topics. It is a testament to the breadth of DT that there are three ISPE Communities of Practice (CoPs) operating in this space, each of whom had submitted high-quality...
The ISPE Drug Shortages Initiative Team conducted a webinar on 9 February 2023 to discuss regulatory and industry insights on drug shortage prevention with a focus on the Asia-Pacific region. The webinar was moderated by Vivien Santillan, Regional Director, Asia, Novatek International. Regulatory speakers were Lisa Hedman, Group Lead for the Division of Supply and Access to Medicines of the...
Following the recent surge in popularity of mRNA technology due to Covid-19 vaccines, we are beginning to realise its impact and potential in this field and for oligonucleotides. However, we face a steep learning curve in understanding the diversity and specifics of the manufacturing chain that make this new generation of RNA drug products completely different from traditional biologics (e.g....